Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Contributor

Brad Thompson, Ph.D.

Brad Thompson, Ph.D., is president and CEO of Oncolytics Biotech, a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics.

More GEN Content From This Contributor